Clinical Trials
Eli Lilly reports positive data from Phase III study...
Eli Lilly and Company has reported positive data from the Phase III study of Cialis/finasteride in men with lower urinary tract symptoms of benign...
Clinical Trials
Diffusion completes enrolling brain cancer patients in TSC Phase...
Diffusion Pharmaceuticals has completed enrolling 56 patients with newly diagnosed primary brain cancer (glioblastoma multiforme or GBM) in the Phase II trial of an...
Clinical Trials
Boston Therapeutics presents PAZ320 drug positive Phase ll results
Boston Therapeutics has presented positive results of its PAZ320 drug, designed for reducing post-meal elevation of blood glucose, from its Phase ll clinical trial....
Clinical Trials
Avaxia treats first patient in ulcerative colitis drug study
Avaxia Biologics has treated the first patient in a Phase1b clinical study using AVX drug dosage, designed for the treatment of ulcerative colitis. ...
Clinical Trials
CSL Behring begins pediatric Phase III hemophilia B study...
CSL Behring has commenced the patient enrollment in pivotal pediatric Phase III hemophilia B study of recombinant fusion protein linking coagulation factor IX with...
Clinical Trials
GlycoMimetics completes enrollment in Phase 2 study of GMI-1070
Clinical-stage biotechnology company GlycoMimetics has completed patient enrollment for the Phase 2 sickle cell disease study evaluating GMI-1070. Hospitalized sickle...
Clinical Trials
Kiadis Pharma raises fund for Phase II study of...
Kiadis Pharma has raised EUR10m in a financing round to conduct Phase II study of a cell based medicinal product candidate, ATIR, and to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.